Clinical Trial Update: Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in advanced bronchioloalveolar carcinoma (adenocarcinoma of the lung) has completed its study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Adenocarcinoma, Bronchiolo-Alveolar | Phase 2 | Status: COMPLETED